1.888.321.7828 sales@pepid.com

The FDA announced emergency use authorization for a rapid, single-use test to detect the Ebola Virus (Zaire ebolavirus). The test, called the DPP Ebola Antigen System (Chembio Diagnostic Systems Inc), is novel for using a portable battery reader for accurate diagnostics outside of a laboratory, where patients are usually treated. Read more about recently authorized DPP Ebola Antigen System here.

[elfsight_social_share_buttons id=”3″]

Share This